2014
Jensen IS , Wu C, Bay CB, Cyr PL . Estimating the clinical value of cangrelor in patients undergoing PCI. International Academy of Cardiology, 19th World Congress on Heart Disease, Boston, MA, 2014.
Publication: Abstracts and Presentations
Wu C, Fortier K, Fan WJ, LePensse K, Bay CB, Cyr PL , Jensen IS . A U.S. hospital budget impact model for oritivancin in ABSSSI patients with risk of MRSA infections. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.
Publication: Abstracts and Presentations
Bay C, Cyr PL , Jensen IS . Estimating the value of cangrelor from eliminating preloading in coronary artery bypass graft (CABG) patients. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.
Publication: Abstracts and Presentations
Pinto DS, Nicholson G, Harrington RA, Cyr PL , Bhatt DL. CHAMPION PHOENIX Study economic results: Direct hospitalization costs of patients receiving clopidogrel or cangralor during percutaneous coronary intervention. American Heart Association QCOR conference, Baltimore, MD, 2014.
Publication: Abstracts and Presentations
Jensen IS , Halbert RJ, Thompson SF, Hennessy D, Pacconi S, McSweeney PA. Increased use of plerixafor in patients with multiple myeloma and non-Hodgkin’s lymphoma in the United States: A budgetary impact analysis. Abstract C14 , Academy of Managed Care Pharmacy 26th Annual Meeting & Expo, 2014.
View Abstract
Publication: Abstracts and Presentations
2013
Jensen IS , Halbert RJ, Grosvenor A, Swartz E, Rossi G, Naoshy S, et al. Incorporating stakeholder input into budget impact models to compare stem cell mobilization strategies. Abstract PCN43 , ISPOR 18th Annual International Meeting, 2013.
View Abstract
Publication: Abstracts and Presentations
Olchanski N, McInnis-Myers M, Halseth M, Cyr PL , Bockstedt L, Goss TF, Howland RH. 2013. The economic burden of treatment-resistant depression. Clin Ther 35(4):512-522; doi: 10.1016/j.clinthera.2012.09.001 .
View Abstract
Publication: Manuscripts
Sacks NC . 2013. Avoidable costs in U.S. healthcare: The $200 billion opportunity from using medicines more responsibly. IMS Health , June.
View Abstract
Publication: Manuscripts
Sacks NC , Burgess JF, Cabral HJ, Pizer SD, McDonnell, ME. 2013. Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries. J Gen Intern Med 28(7):876–885.
View Abstract
Publication: Manuscripts
Cyr P , Sidhu M, Hussain R, Hromin T, Jensen I , Kuan R. Dual-acting osmotic and stimulant laxative for bowel cleansing in an elderly population: A US payer budget impact analysis. Abstract PCN22 , ISPOR 18th Annual International Meeting, 2013.
View Abstract
A Division of